Esperion Therapeutics Inc ESPR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.84
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 240
- Website
- https://www.esperion.com
Comparables
Valuation
|
Metric
|
ESPR
|
TRVI
|
EWTX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 3.38 | 4.75 |
Price/Sales | 0.84 | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
ESPR
TRVI
EWTX
Financial Strength
|
Metric
|
ESPR
|
TRVI
|
EWTX
|
|---|---|---|---|
Quick Ratio | 1.42 | 10.29 | 29.79 |
Current Ratio | 1.97 | 10.68 | 30.24 |
Interest Coverage | −0.70 | −4,780.89 | — |
Quick Ratio
ESPR
TRVI
EWTX
Profitability
|
Metric
|
ESPR
|
TRVI
|
EWTX
|
|---|---|---|---|
Return on Assets (Normalized) | −11.97% | −40.88% | −23.23% |
Return on Equity (Normalized) | — | −44.19% | −24.43% |
Return on Invested Capital (Normalized) | — | −48.62% | −29.19% |
Return on Assets
ESPR
TRVI
EWTX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bzrbszpl | Xsxx | $86.8 Bil | |||
| Merck KGaA ADR
MKKGY
| Dqrztyrn | Xlstymz | $75.4 Bil | |||
| Haleon PLC ADR
HLN
| Hqkvzgvsy | Ftzsw | $48.1 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Tpvdmqg | Cnhbq | $20.0 Bil | |||
| Viatris Inc
VTRS
| Dgrrxth | Qsb | $13.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qhxkjpcc | Yctn | $13.3 Bil | |||
| Catalent Inc
CTLT
| Pcjbtmyk | Nthjbwm | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Cdtmswbzj | Lybhp | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Bxcwwpvrm | Jlv | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Slqrcwjwn | Dklrm | $2.5 Bil |
United States